Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages
- 18 July 2009
- Vol. 27 (41) , 5574-5580
- https://doi.org/10.1016/j.vaccine.2009.07.036
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- A Randomized Trial to Determine the Tolerability and Immunogenicity of a Quadrivalent Meningococcal Glycoconjugate Vaccine in Healthy AdolescentsThe Pediatric Infectious Disease Journal, 2009
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd ImmunityThe Journal of Infectious Diseases, 2008
- Reconsideration of the Use of Meningococcal Polysaccharide VaccineThe Pediatric Infectious Disease Journal, 2007
- Towards an improved serogroup BNeisseria meningitidisvaccineExpert Opinion on Biological Therapy, 2005
- Prevention and Control of Meningococcal Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric PatientsPediatrics, 2005
- Effects of Prior Polysaccharide Vaccination on Magnitude, Duration, and Quality of Immune Responses to and Safety Profile of a Meningococcal Serogroup C Tetanus Toxoid Conjugate Vaccination in AdultsClinical and Vaccine Immunology, 2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infantsThe Pediatric Infectious Disease Journal, 1993
- Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccinesThe Journal of Pediatrics, 1992
- AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINEThe Lancet, 1985